Plus: What’s ahead for 13 weight-loss drugs in the pipeline.
September 9, 2026

1. FDA warns clinicians on compounded GLP-1s amid 1,700+ safety reports Full story

2. Pancreatic cancer drug shrank tumors for 1 in 3 lung cancer patients: Early trial Full story

3. Same procedure, different physician, different cost. See how UChicago Medicine finds the outliers here.

 

4. FDA approves 1st-of-its-kind breast cancer treatment Full story

5. 13 weight-loss drugs in the pipeline: What’s ahead for each Full story

6. UT Southwestern is making the OR visible in real time across teams. Learn how here.

 

7. Novartis pauses CAR-T trials for autoimmune diseases after 3 deaths Full story

8. GLP-1 use among children rapidly rising in US: 5 notes Full story

Becker’s Learning Opportunities

9. Burnout, turnover and agency spend aren’t separate problems. See the connected fix here.

10. How 2 systems built nurse readiness that lasts beyond orientation here.

11. HCA Florida West Marion on where stroke recovery is really won in this Sept. 28 webinar.

12. Becker’s September webinar lineup: hospital AI, nonopioid pain care and analytics governance. See the sessions here.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication